| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Zivo Bioscience, Inc. (ZIVO) has 4 insiders with recent SEC Form 4 filings, including 10 buys and 1 sell. ZIVO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 577.9K | $2.17M | - | |
| 10% | 517.5K | $1.94M | - | |
| 10% | 452.9K | $1.70M | - | |
| Dir | 1.2K | $4.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 28, 2025 | Yaldoo Laith L | Director, 10% Owner | Buy | 2,777 | $9.00 | $24,993.00 | +0.5% | |
| Oct 13, 2025 | Strome Mark E | 10% Owner | Buy | 20,259 | $12.34 | $249,996.06 | +4.7% | |
| Oct 10, 2025 | Yaldoo Laith L | Director, 10% Owner | Buy | 1,659 | $12.05 | $19,990.95 | +0.3% | |
| Oct 8, 2025 | Maggiore Christopher D. | Director, 10% Owner | Buy | 23,682 | $12.01 | $284,420.82 | +4.8% | |
| Sep 30, 2025 | Yaldoo Laith L | Director, 10% Owner | Buy | 15,322 | $15.99 | $244,998.78 | +2.7% | |
| Jun 13, 2025 | Yaldoo Laith L | Director, 10% Owner | Buy | 3,488 | $14.33 | $49,983.04 | +0.6% | |
| Apr 8, 2025 | Maggiore Christopher D. | Director, 10% Owner | Sell | 20 | $16.25 | $325.00 | - | |
| Jan 22, 2025 | Yaldoo Laith L | Director, 10% Owner | Buy | 10,080 | $17.53 | $176,682.24 | +0.9% | |
| Dec 26, 2024 | Strome Mark E | 10% Owner | Buy | 75,000 | $20.19 | $1,514,250.00 | +23.2% | |
| Oct 16, 2024 | Payne John Bernard | President And CEO | Buy | 6,343 | $15.76 | $99,965.68 | +405.0% |